Longevity & Aging
Bacterial Immunotherapy Enters Human Trials for Deadliest Pancreatic Cancer
Matter Bio files first IND for Listeria-based therapy targeting pancreatic cancer, merging oncology and longevity science.
Press Release
May 20, 2026 0
All Articles
7263 articles
Brain Health
ML Pipeline Advances Detection of Age-Related Brain Microbleeds in Mouse Model
Researchers built a machine learning imaging pipeline to detect cerebral microhemorrhages and tested SS-31 (elamipretide) in aged hypertensive mice.
Research Paper
May 20, 2026 0
Heart Health
Barth Syndrome Management Gets a Boost With Targeted Elamipretide Therapy
A comprehensive GeneReviews update on Barth syndrome outlines diagnosis, new targeted therapy, and surveillance strategies for this rare X-linked disorder.
Research Paper
May 20, 2026 0
Regenerative Medicine
Mitochondrial Myopathies in 2025: What Treatments Actually Work
A comprehensive review of pathophysiology, genetics, and emerging therapies for mitochondrial myopathies, spotlighting elamipretide and gene therapy.
Research Paper
May 20, 2026 0
Heart Health
Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair
The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.
Research Paper
May 20, 2026 0
Heart Health
Mitochondrial Protein GTPBP3 Found Essential for Blood Vessel Growth and Ischemia Recovery
Deleting GTPBP3 in endothelial cells blocks angiogenesis via mtROS overload — and a mitochondria-targeted antioxidant reverses the damage.
Research Paper
May 20, 2026 0
Cancer Research
Personalized Medicine Is Reshaping How We Treat the Deadliest Ovarian Cancer
A comprehensive review in CA Cancer J Clin maps the molecular biology, treatment strategies, and equity gaps in high-grade serous ovarian cancer.
Research Paper
May 20, 2026 0
Heart Health
Two-Year Plant-Based Supplement Trial for Inflammaging in Overweight Seniors Terminated Early
A 2-year clinical trial testing Juice Plus+ products against low-grade inflammation and biological aging markers in overweight seniors was terminated before completion.
Clinical Trial
May 20, 2026 0
Heart Health
Inflammaging Biomarkers Causally Reshape Retinal Vessels and Predict Cardiovascular Fate
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.
Research Paper
May 20, 2026 0
Regenerative Medicine
Stem Cell Therapy Laromestrocel Boosts Walking Ability in Frail Older Adults
A phase 2b trial finds allogeneic MSC infusions improved 6-minute walk distance by 63 meters vs placebo at 9 months in frail older adults.
Research Paper
May 20, 2026 0
Heart Health
How Your Heart Ages and What Science Can Do to Slow It Down
A 2025 review maps the molecular mechanisms driving cardiovascular aging—from inflammaging to ECM remodeling—and outlines emerging therapies.
Research Paper
May 20, 2026 0
Autoimmune & Arthritis
UK Trial of Biologics for Refractory Rare Vasculitis Terminated Early
A Phase 2 trial testing rituximab, infliximab, and tocilizumab for hard-to-treat non-ANCA vasculitis was terminated before completion.
Clinical Trial
May 20, 2026 0